Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2022 09:00 ET | Source: Invectys, Inc.

Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference

Houston, Texas, USA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Invectys Inc. will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Praveen Tyle, Ph.D., Invectys Inc....
January 06, 2022 08:00 ET | Source: Daxor Corporation

Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh...
January 06, 2022 06:00 ET | Source: BioRestorative Therapies, Inc

BioRestorative Therapies to Present at H.C. Wainwright BioConnect Virtual Conference

MELVILLE, N.Y., Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies,...
January 05, 2022 08:30 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
January 05, 2022 07:00 ET | Source: Silence Therapeutics plc

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conference 5 January 2022 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a...
January 04, 2022 08:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals to Present at the H.C. Wainwright BioConnect Conference

PHILADELPHIA, PA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
January 04, 2022 08:00 ET | Source: Cocrystal Pharma, Inc.

Cocrystal Pharma to Present at the H.C. Wainwright BioConnect Virtual Conference

BOTHELL, Wash., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will present a company overview at the H.C....
January 04, 2022 08:00 ET | Source: Onconova Therapeutics, Inc.

Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
January 04, 2022 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus to Participate at H.C. Wainwright Bioconnect Virtual Conference

WARMINSTER, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and...
January 08, 2021 08:30 ET | Source: Daxor Corporation

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned...

Next Page keyboard_arrow_right